ID27810A - Antibodi menoclonal anti v-integrin dan kegunaan untuk mencegah penambahan v 6-integrin untuk fibronectin - Google Patents

Antibodi menoclonal anti v-integrin dan kegunaan untuk mencegah penambahan v 6-integrin untuk fibronectin

Info

Publication number
ID27810A
ID27810A IDW20001566A ID20001566A ID27810A ID 27810 A ID27810 A ID 27810A ID W20001566 A IDW20001566 A ID W20001566A ID 20001566 A ID20001566 A ID 20001566A ID 27810 A ID27810 A ID 27810A
Authority
ID
Indonesia
Prior art keywords
integrin
menoclonal
fibronectin
antibody
prevent
Prior art date
Application number
IDW20001566A
Other languages
English (en)
Indonesian (id)
Inventor
Simon Goodman
Beate Diefenbach
Francesc Mitjans
Ana Carceller
Elisabet Rosell-Vives
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID27810A publication Critical patent/ID27810A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW20001566A 1998-01-23 1999-01-11 Antibodi menoclonal anti v-integrin dan kegunaan untuk mencegah penambahan v 6-integrin untuk fibronectin ID27810A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98101108 1998-01-23

Publications (1)

Publication Number Publication Date
ID27810A true ID27810A (id) 2001-04-26

Family

ID=8231295

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001566A ID27810A (id) 1998-01-23 1999-01-11 Antibodi menoclonal anti v-integrin dan kegunaan untuk mencegah penambahan v 6-integrin untuk fibronectin

Country Status (17)

Country Link
EP (1) EP1049718B1 (de)
JP (1) JP2002501086A (de)
KR (1) KR20010034327A (de)
CN (1) CN1168741C (de)
AR (1) AR014464A1 (de)
AT (1) ATE322508T1 (de)
AU (1) AU2716399A (de)
BR (1) BR9907218A (de)
CA (1) CA2319160A1 (de)
DE (1) DE69930723T2 (de)
HU (1) HUP0101151A3 (de)
ID (1) ID27810A (de)
NO (1) NO20003767L (de)
PL (1) PL341569A1 (de)
SK (1) SK10772000A3 (de)
WO (1) WO1999037683A1 (de)
ZA (1) ZA99453B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176195B1 (de) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Verfahren zur kontrolle der aktivität von immunologisch funktionellem molekül
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
EP1381384B1 (de) 2001-04-24 2011-05-25 Merck Patent GmbH KOMBINATIONSTHERAPIE MIT ANTIANGIOGENEN MITTELN UND TNFalpha
EP1414491A4 (de) 2001-07-09 2005-07-06 Elan Pharm Inc Verfahren zur hemmung der toxizität von amyloid
US7829087B2 (en) 2001-07-09 2010-11-09 Elan Pharmaceuticals, Inc. Methods of treating cognitive impairment
MXPA04008870A (es) 2002-03-13 2005-06-17 Biogen Idec Inc Anticuerpos anti-avb6.
CN102875681A (zh) * 2005-07-08 2013-01-16 拜奥根Idec马萨诸塞公司 抗-αvβ6抗体及其用途
EP1973569B1 (de) 2006-01-18 2013-05-22 Merck Patent GmbH Spezifische therapie mit integrin-liganden zur krebsbehandlung
AR060040A1 (es) 2006-03-21 2008-05-21 Genentech Inc Antagonistas de vefg y de alfa5 beta 1
CN101563105B (zh) 2006-07-10 2013-01-23 拜奥根Idec马萨诸塞公司 用于抑制smad4-缺陷癌症的组合物和方法
EP2064244B1 (de) 2006-08-03 2019-06-05 MedImmune Limited GEGEN alphaVbeta6 GERICHTETE ANTIKÖRPER UND IHRE VERWENDUNG
JP2010516645A (ja) 2007-01-18 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌を治療するためのインテグリンリガンドを用いる特異的療法および薬剤
TWI547503B (zh) 2007-09-26 2016-09-01 建南德克公司 抗α5β1抗體、編碼其之核酸、包含其之組合物及其製造及使用方法
JP5637855B2 (ja) 2007-11-08 2014-12-10 ザ ジェネラル ホスピタル コーポレイション 蛋白尿症の治療のための方法及び組成物
AU2010229479B2 (en) 2009-03-25 2013-03-28 Genentech, Inc. Novel anti-alpha5beta1 antibodies and uses thereof
US20120130146A1 (en) 2009-05-25 2012-05-24 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
CN105315370A (zh) * 2010-02-18 2016-02-10 加利福尼亚大学董事会 整合素αVβ8中和抗体
US10035860B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
WO2014144466A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0719859T3 (da) * 1994-12-20 2003-10-20 Merck Patent Gmbh Anti-alfa V-integrin monoklonalt antistof

Also Published As

Publication number Publication date
EP1049718B1 (de) 2006-04-05
HUP0101151A3 (en) 2004-06-28
SK10772000A3 (sk) 2001-01-18
WO1999037683A1 (de) 1999-07-29
DE69930723D1 (de) 2006-05-18
KR20010034327A (ko) 2001-04-25
EP1049718A1 (de) 2000-11-08
ZA99453B (en) 1999-07-21
CN1288469A (zh) 2001-03-21
AR014464A1 (es) 2001-02-28
HUP0101151A2 (hu) 2001-08-28
JP2002501086A (ja) 2002-01-15
NO20003767D0 (no) 2000-07-21
ATE322508T1 (de) 2006-04-15
BR9907218A (pt) 2000-10-24
CA2319160A1 (en) 1999-07-29
PL341569A1 (en) 2001-04-23
AU2716399A (en) 1999-08-09
NO20003767L (no) 2000-07-21
CN1168741C (zh) 2004-09-29
DE69930723T2 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
ID27810A (id) Antibodi menoclonal anti v-integrin dan kegunaan untuk mencegah penambahan v 6-integrin untuk fibronectin
DK0719859T3 (da) Anti-alfa V-integrin monoklonalt antistof
ID26707A (id) Katalisator untuk produksi-olefin dan metode produksi-olefin
ID20463A (id) Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea
ID27145A (id) Metode untuk memproduksi polioksialkilena poliol dan turunan-turunannya
ID23953A (id) Asam 5-alkil-2-arilaminofenilasetat dan turunannya
ID23978A (id) Turunan-turunan tienopirimidin dan tienopiridin yang berguna sebagai zat-zat anti kangker
ID26570A (id) Pembawa rekaman dan perangkat untuk menscanning pembawa rekamannya
ID26282A (id) Film poliester dan metode untuk membuatnya
ID26599A (id) Turunan triazola dan imidazola
ID28088A (id) Antibodi untuk cd23, turunan-turunannya dan penggunannya untuk terapi
FI964845L (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
ID25573A (id) Dongkrak jenis pantograf dan proses untuk memproduksinya
ID24872A (id) Komposisi pengawet berdasarkan senyawa donor formaldehide dan iodopropinil
DE69738312D1 (de) Hepatitis b monoklonale antikörper
ID16796A (id) ANTIBODI ANTI-FAS REKOMBINAN DAN DNA-nya
ID24463A (id) Metode meningkatkan ketersediaan hayati feksofenadin dan turunan-turunannya
ID27089A (id) Aparatus perekaman dan metode perekaman
ID24241A (id) Metoda dan sistem untuk mencari petunjuk cepat
ID26979A (id) Zat pelapis dan penggunaanya
ID21895A (id) Antibodi yang mengikat kepada grup laminin yang mengikat nidogen, pembuatannya dan penggunaannya
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
NO20020253L (no) Katalytiske anti-faktor VIII allo-antistoffer
ID21494A (id) Kolam kultur air dan metoda untuk konstruksinya
KR950030817U (ko) 차량용 클립구조